Circumventing Immunogenicity in Gene Therapy With Svec, a Novel SV40 Based Viral Vector Platform

Time: 2:30 pm
day: Day 2 Track 1 PM

Details:

  • The crucial role of immunity and tolerance in gene therapy
  • Features and development of the SVec platform in Haemophilia
  • Opening new frontiers in gene therapy: Potential to restore tolerance in autoimmunity

Speakers: